0001998781 2024-10-01 2024-12-31 0001998781 IBAC:SharesOfCommonStockParValue0.0001PerShareMember 2024-10-01 2024-12-31 0001998781 IBAC:RightsEachEntitlingHolderToReceiveOnetwentiethOfOneShareOfCommonStockMember 2024-10-01 2024-12-31 0001998781 2025-02-12 0001998781 2024-12-31 0001998781 2024-09-30 0001998781 2023-10-01 2023-12-31 0001998781 IBAC:RedeemableCommonStockMember 2024-10-01 2024-12-31 0001998781 IBAC:RedeemableCommonStockMember 2023-10-01 2023-12-31 0001998781 IBAC:NonredeemableCommonStockMember 2024-10-01 2024-12-31 0001998781 IBAC:NonredeemableCommonStockMember 2023-10-01 2023-12-31 0001998781 srt:MaximumMember 2023-10-01 2023-12-31 0001998781 us-gaap:CommonStockMember 2024-09-30 0001998781 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001998781 us-gaap:RetainedEarningsMember 2024-09-30 0001998781 us-gaap:CommonStockMember 2023-09-30 0001998781 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001998781 us-gaap:RetainedEarningsMember 2023-09-30 0001998781 2023-09-30 0001998781 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001998781 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001998781 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001998781 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001998781 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001998781 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001998781 us-gaap:CommonStockMember 2024-12-31 0001998781 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001998781 us-gaap:RetainedEarningsMember 2024-12-31 0001998781 us-gaap:CommonStockMember 2023-12-31 0001998781 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001998781 us-gaap:RetainedEarningsMember 2023-12-31 0001998781 2023-12-31 0001998781 us-gaap:IPOMember 2024-03-28 2024-03-28 0001998781 us-gaap:OverAllotmentOptionMember 2024-03-28 2024-03-28 0001998781 us-gaap:OverAllotmentOptionMember 2024-03-28 0001998781 us-gaap:PrivatePlacementMember 2024-03-28 2024-03-28 0001998781 us-gaap:PrivatePlacementMember 2024-03-28 0001998781 2024-03-28 0001998781 2024-03-28 2024-03-28 0001998781 IBAC:IBankersSecuritiesIncMember us-gaap:IPOMember 2024-03-28 2024-03-28 0001998781 2023-10-01 2024-09-30 0001998781 IBAC:FounderSharesMember 2020-09-02 2020-09-02 0001998781 IBAC:FounderSharesMember 2023-10-26 2023-10-26 0001998781 IBAC:FounderSharesMember 2023-10-26 0001998781 IBAC:FounderSharesMember 2024-03-28 2024-03-28 0001998781 IBAC:FounderSharesMember 2024-03-28 0001998781 IBAC:SponsorMember 2024-12-31 0001998781 IBAC:SponsorMember 2024-09-30 0001998781 IBAC:SponsorMember us-gaap:PrivatePlacementMember 2022-10-01 2023-09-30 0001998781 IBAC:SponsorMember us-gaap:PrivatePlacementMember 2023-09-30 0001998781 IBAC:FounderSharesMember IBAC:SubscriptionAgreementMember 2023-10-01 2024-01-31 0001998781 IBAC:FounderSharesMember IBAC:SubscriptionAgreementMember 2024-01-31 0001998781 IBAC:FounderSharesMember 2024-01-31 0001998781 IBAC:FounderSharesMember IBAC:SubscriptionAgreementMember 2024-01-22 2024-01-22 0001998781 IBAC:FounderSharesMember us-gaap:OverAllotmentOptionMember IBAC:SubscriptionAgreementMember 2024-01-22 2024-01-22 0001998781 IBAC:FounderSharesMember us-gaap:OverAllotmentOptionMember 2024-01-22 0001998781 IBAC:FounderSharesMember IBAC:SubscriptionAgreementMember 2024-09-11 2024-09-11 0001998781 IBAC:FounderSharesMember us-gaap:OverAllotmentOptionMember IBAC:SubscriptionAgreementMember 2024-09-11 2024-09-11 0001998781 IBAC:FounderSharesMember us-gaap:OverAllotmentOptionMember 2024-09-11 0001998781 IBAC:FounderSharesMember IBAC:SponsorMember IBAC:SubscriptionAgreementMember 2024-09-11 2024-09-11 0001998781 IBAC:FounderSharesMember us-gaap:OverAllotmentOptionMember 2024-09-11 2024-09-11 0001998781 IBAC:DirectorsAndDirectorNomineesMember IBAC:SubscriptionAgreementMember 2024-03-28 2024-03-28 0001998781 IBAC:DirectorsAndDirectorNomineesMember IBAC:SubscriptionAgreementMember 2024-03-28 0001998781 IBAC:DirectorsAndDirectorNomineesMember IBAC:SubscriptionAgreementMember 2024-09-12 2024-09-12 0001998781 IBAC:DirectorsAndDirectorNomineesMember IBAC:SubscriptionAgreementMember 2024-09-12 0001998781 srt:ChiefFinancialOfficerMember 2023-10-01 2023-10-01 0001998781 srt:ChiefFinancialOfficerMember 2024-01-22 2024-01-22 0001998781 srt:ChiefFinancialOfficerMember 2024-10-01 2024-12-31 0001998781 srt:ChiefFinancialOfficerMember 2024-12-31 0001998781 srt:ChiefFinancialOfficerMember 2023-10-01 2023-12-31 0001998781 srt:ChiefFinancialOfficerMember 2023-12-31 0001998781 us-gaap:MeasurementInputPriceVolatilityMember IBAC:FounderSharesMember 2023-11-15 0001998781 us-gaap:MeasurementInputPriceVolatilityMember IBAC:FounderSharesMember 2024-01-15 0001998781 us-gaap:MeasurementInputRiskFreeInterestRateMember IBAC:FounderSharesMember 2023-11-15 0001998781 us-gaap:MeasurementInputRiskFreeInterestRateMember IBAC:FounderSharesMember 2024-01-15 0001998781 us-gaap:MeasurementInputSharePriceMember IBAC:FounderSharesMember 2023-11-15 0001998781 us-gaap:MeasurementInputSharePriceMember IBAC:FounderSharesMember 2024-01-15 0001998781 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember IBAC:FounderSharesMember 2023-11-15 0001998781 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember IBAC:FounderSharesMember 2024-01-15 0001998781 us-gaap:IPOMember IBAC:UnderwritersAgreementMember 2024-03-28 2024-03-28 0001998781 us-gaap:IPOMember IBAC:UnderwritersAgreementMember 2024-03-28 0001998781 IBAC:UnderwritersAgreementMember 2024-03-28 2024-03-28 0001998781 IBAC:UnsecuredPromissoryNoteMember IBAC:SuDeTangGlobalCorporationMember 2024-09-16 0001998781 IBAC:UnsecuredPromissoryNoteMember IBAC:SuDeTangGlobalCorporationMember 2024-12-31 0001998781 us-gaap:USTreasurySecuritiesMember 2024-12-31 0001998781 us-gaap:USTreasurySecuritiesMember 2024-09-30 0001998781 us-gaap:FairValueInputsLevel1Member 2024-12-31 0001998781 us-gaap:FairValueInputsLevel1Member 2024-09-30 iso4217:USD shares iso4217:USD shares pure IBAC:Segment false --09-30 Q1 2025 0001998781

10-Q true 2024-12-31 false 001-41988 IB ACQUISITION CORP. NV 85-2946784 1200 N Federal Highway Suite 215 Boca Raton FL 33432 (214) 687-0020 Shares of common stock, par value $0.0001 per share IBAC NASDAQ Rights, each entitling the holder to receive one-twentieth of one share of common stock IBACR NASDAQ Yes Yes Non-accelerated Filer true true false true 15749090 0.0001

910193

822799

8329

36216

254625

339500

1173147

1198515

119658403

118601873

120831550

119800388

90162

86718

608533

635512

147629

846324

722230

846324

722230

11500000

10.35

10.26

119049870

117966361

0.0001

10000000

0.0001

100000000

4249090

425

934931

1111372

935356

1111797

120831550

119800388

176441

87491

-176441

-87491

1371530

1195089

-87491

288021

907068

-87491

11500000

0.06

4249090

2820513

0.06

-0.03

423077

4249090

425

1111372

1111797

-1083509 -1083509

907068

4249090

425

934931

935356

3243590

324

2676

-8434

-5434

3243590

324

2676

-8434

-5434

-87491

3243590

324

2676

-95925

-92925

3243590

324

2676

-95925

-92925

423077

907068

-87491

1371530

-27887

10000

-84875

3444

14452

5000

-26979

-375235

-78039

315000

147629

250000 -44862

147629

205138

87394

127099

822799

52553

910193

179652

1083509 117065

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS IB Acquisition Corp. f/k/a I-B Good Works 4 Corporation (the “Company”) is a blank check company originally incorporated under the laws of the State of Delaware on July 7, 2020 and which converted to a Nevada corporation on September 21, 2023 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any potential business combination target, and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any potential business combination target with respect to an initial business combination with the Company. The Company’s investment strategy is not specific to any sector, however, the management team and board members believe there are compelling investment opportunities in a number of areas including consumer goods, sports and entertainment, and healthcare technology. The Company anticipates targeting companies domiciled in North America, Europe and Asia, with an enterprise value of at least $500 million. As of December 31, 2024, the Company had not yet commenced any operations. All activity through December 31, 2024, relates to the Company’s formation, initial public offering (the “Initial Public Offering” as further defined below) and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income on cash and cash equivalents in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected September 30 as its fiscal year end. The registration statement for the Company’s Initial Public Offering was declared effective on March 25, 2024. On March 28, 2024, the Company consummated the Initial Public Offering of 11,500,000 units (the “Units”), which includes the full exercise by the underwriters of their over-allotment option in the amount of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240328__20240328__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zXsoDXi79WR3" title="Number of units sold">1,500,000 Units, at a purchase price of $10.00 per Unit, generating gross proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240328__20240328__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z5kaHZPbac84" title="Gross proceeds from issuance">115,000,000, which is discussed in Note 3. Each Unit consists of one share of the Company’s common stock, and one right. Each right entitles the holder thereof to receive one-twentieth (1/20) of one share of common stock upon the consummation of the Business Combination. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 610,500 Units (the “Private Placement Units”) at a price of $10.00 per Unit in a private placement to the Company’s sponsor, I-B Good Works 4, LLC (the “Sponsor”), which is an affiliate of I-Bankers Securities, Inc. (“I-Bankers”). The Private Placement Units are identical to the units sold in the Initial Public Offering. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. Transaction costs amounted to $7,755,845 consisting of the fair value amount of $3,867,050 related with the issued representative shares, $3,450,000 of cash underwriting discount, and $438,795 of other offering costs. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding any M&A fees (see note 6) held in the Trust Account and taxes payable on the interest earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Initial Public Offering, management has agreed that $10.05 per Unit sold in the Initial Public Offering, including proceeds of the sale of the Private Placement Units, will be held in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below. The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.05 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. The shares of common stock were recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such completion of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. IB ACQUISITION CORP. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2024 (Unaudited) If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders, which are holders of the Founder Shares, have agreed to (i) waive their redemption rights with respect to their Private Placement Shares (as defined below) in connection with the completion of the Business Combination, (ii) waive their redemption rights with respect to their Founder Shares (defined below), Private Placement Shares (defined below) and any Public Shares they hold in connection with a stockholder vote to approve an amendment to the Company’s amended and restated articles of incorporation (a) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete the Business Combination within 18 months from the closing of the Initial Public Offering or (b) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares and Private Placement Shares if the Company fails to complete the Business Combination within 18 months from the closing of the Proposed Public Offering. In addition, the Sponsor has agreed to vote any Private Placement Shares held by it in favor of the Business Combination. Additionally, each public stockholder may elect to redeem its Public Shares, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s amended and restated articles of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares. The Company will have until 18 months from the closing of the Initial Public Offering (the “Combination Period”) to complete a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will <span id="xdx_908_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20240328__20240328__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--BusinessAcquisitionAxis__custom--IBankersSecuritiesIncMember_zH8bXSpzwUy2" title="Business combination description">(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses, which shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Nevada law to provide for claims of creditors and the requirements of other applicable law. The initial stockholders have agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The Underwriters will not receive their M&A fee (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.05). The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.05 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the Underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”), in connection with both our initial public offering and the business combination. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties The impact of current conflicts around the globe, including Russia’s invasion of Ukraine and the Israel - Hamas war, and related sanctions, on the world economy is not determinable as of the date of these unaudited financial statements, and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited financial statements. Going Concern Consideration As of December 31, 2024, the Company had $910,193 in cash and a working capital of $326,823. In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company currently lacks the liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the unaudited financial statements are issued as it expects to continue to incur significant costs in pursuit of its acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to address this uncertainty through a Business Combination. There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful within the Combination Period. The unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty. IB ACQUISITION CORP. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2024 (Unaudited)

500000000

11500000

1500000

10.00

115000000

610500

10.00

7755845

3867050

3450000

438795

10.05

5000001 1

(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses, which shall be net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Nevada law to provide for claims of creditors and the requirements of other applicable law.

10.05

910193

326823

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited financial statements prepared in accordance with GAAP have been or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended September 30, 2024, as filed with the SEC on December 26, 2024. The interim results for the three months ended December 31, 2024, are not necessarily indicative of the results to be expected for the year ending September 30, 2025 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of unaudited financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. The Company had $910,193 and $822,799 in cash as of December 31, 2024, and September 30, 2024, respectively, and no cash equivalents. Marketable securities held in Trust account As of December 31, 2024, all of the assets held in the Trust Account were held in money market funds which are invested only in U.S. government securities. Investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Interest income earned from investments in these securities are included in the accompanying unaudited statements of operations. Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist principally of professional and registration fees, cash underwriting discount, and deferred underwriting fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on relative fair value basis, compared to total proceeds received. Offering costs allocated to the Public Shares were charged against the carrying value of ordinary shares subject to possible redemption upon the completion of the Initial Public Offering and offering costs allocated to Public Rights (as defined in Note 3) were charged to additional paid in capital at the completion of the Initial Public Offering. IB ACQUISITION CORP. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2024 (Unaudited) Common Stock Subject to Possible Redemption The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial business combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering were issued with other freestanding instruments (i.e., Public Rights) and as such, the initial carrying value of Public Shares classified as temporary equity are the allocated proceeds determined in accordance with ASC 470-20. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against retained earnings or additional paid-in capital in the absence of retained earnings. Accordingly, as of December 31, 2024, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares are affected by charges against retained earnings or additional paid-in capital in the absence of retained earnings. As of December 31, 2024, the common stock subject to redemption reflected in the balance sheet are reconciled in the following table: SCHEDULE OF COMMON STOCK SUBJECT TO REDEMPTION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_4BB_zGtiNLNdPmz2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">Gross proceeds</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--GrossProceedsSubjectToRedemption_c20231001__20240930_zTZr3ODmZtki" style="width: 18%; text-align: right" title="Gross proceeds">115,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Proceeds allocated to Public Rights</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ProceedsAllocatedToPublicRights_c20231001__20240930_zwOtqg79Z5Kh" style="text-align: right" title="Proceeds allocated to Public Rights">(2,415,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common stock issuance costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--TemporaryEquityStockIssuedDuringPeriodValueNewIssues_iN_di_c20231001__20240930_zgmIPnsAYbpk" style="text-align: right" title="Common stock issuance costs">(7,571,317</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20231001__20240930_zCoUqqJ4Dn6b" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value">12,952,678</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_439_c20241001__20241231_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zTDtw5BhKbJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Common stock subject to possible redemption, September 30, 2024</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">117,966,361</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--TemporaryEquityAccretionToRedemptionValue_zy0AGgIVaap8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,083,509</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_43D_c20241001__20241231_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zGpGXS5KFXzg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Common stock subject to possible redemption, December 31, 2024</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">119,049,870</td><td style="text-align: left"> </td></tr> </table> Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of December 31, 2024 and September 30, 2024, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our effective tax rate was (24.1)% for the three months ended December 31, 2024. Our effective tax rate was 0.00% for the three months ended December 31, 2023. The effective tax rate differs from the statutory tax rate of 21% for December 31, 2024 and September 30, 2024, due to the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s unaudited financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 and September 30, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) Per Common Stock The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the period. Accretion associated with the redeemable shares of common stock is excluded from earnings (loss) per share as the redemption value approximates fair value. The calculation of diluted net income (loss) per share does not consider the effect of the rights issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the rights are contingent upon the occurrence of future events. As of December 31, 2024, the rights are exercisable to purchase 605,525 shares of common stock in the aggregate. The weighted average of these shares was excluded from the calculation of diluted net income (loss) per common stock since the inclusion of such rights would be anti-dilutive. The rights cannot be converted to shares of common stock prior to an initial Business Combination; therefore, they have been classified as anti-dilutive. IB ACQUISITION CORP. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2024 (Unaudited) The following table reflects the calculation of basic and diluted net income (loss) per common stock (in dollars, except per share amounts): SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER COMMON STOCK <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z2TfgAiCKK9b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_znB06TMnlDf3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zsrXBFQPQ6ne" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z28SzaMIFYDa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended December 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareAbstract_iB_zFSE8pbB0XO3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Basic and diluted net income (loss) per common share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 14.55pt">Allocation of net income (loss)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">662,342</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">244,726</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(87,491</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.25pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 14.55pt">Basic and diluted weighted-average shares outstanding</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zP7jN50V9Rdj" title="Basic weighted-average shares outstanding"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zLUITxbsJPz7" title="Diluted weighted average shares outstanding">11,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_ztONMZrS9VV5" title="Basic weighted-average shares outstanding"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zO8SHPJDaOFj" title="Diluted weighted average shares outstanding">4,249,090</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z4njiOjsgD1d" title="Basic weighted-average shares outstanding"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zfqEEpOsHaW2" title="Diluted weighted average shares outstanding">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z1GQJoJAUam6" title="Basic weighted-average shares outstanding"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zpefVad2y405" title="Diluted weighted average shares outstanding">2,820,513</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic and diluted net income (loss) per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3LRVxL89Ue" title="Diluted net income (loss) per common share">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z7CNrK4yzVtf" title="Basic net income (loss) per common share"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zc0uNtp09VIe" title="Diluted net income (loss) per common share">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EarningsPerShareDiluted_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zDtCzNDxsHw9" title="Diluted net income (loss) per common share">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EarningsPerShareBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyeBAgmPnbG6" title="Basic net income (loss) per common share"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zNrCK9mYN9Sa" title="Diluted net income (loss) per common share">(0.03</td><td style="text-align: left">)</td></tr> </table> Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on the cash account and management believes that the Company is not exposed to significant risks on such account. Uninsured cash amount as of December 31, 2024, is $660,193. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Recent Accounting Standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited financial statements.

Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited financial statements prepared in accordance with GAAP have been or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended September 30, 2024, as filed with the SEC on December 26, 2024. The interim results for the three months ended December 31, 2024, are not necessarily indicative of the results to be expected for the year ending September 30, 2025 or for any future periods.

Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates The preparation of unaudited financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. The Company had $910,193 and $822,799 in cash as of December 31, 2024, and September 30, 2024, respectively, and no cash equivalents.

910193

822799

Marketable securities held in Trust account As of December 31, 2024, all of the assets held in the Trust Account were held in money market funds which are invested only in U.S. government securities. Investments in money market funds are presented on the balance sheet at fair value at the end of each reporting period. Interest income earned from investments in these securities are included in the accompanying unaudited statements of operations.

Offering Costs The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist principally of professional and registration fees, cash underwriting discount, and deferred underwriting fees incurred through the balance sheet date that are related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on relative fair value basis, compared to total proceeds received. Offering costs allocated to the Public Shares were charged against the carrying value of ordinary shares subject to possible redemption upon the completion of the Initial Public Offering and offering costs allocated to Public Rights (as defined in Note 3) were charged to additional paid in capital at the completion of the Initial Public Offering.

Common Stock Subject to Possible Redemption The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial business combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the Initial Public Offering were issued with other freestanding instruments (i.e., Public Rights) and as such, the initial carrying value of Public Shares classified as temporary equity are the allocated proceeds determined in accordance with ASC 470-20. The Company recognizes changes in redemption value immediately as it occurs and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against retained earnings or additional paid-in capital in the absence of retained earnings. Accordingly, as of December 31, 2024, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares are affected by charges against retained earnings or additional paid-in capital in the absence of retained earnings. As of December 31, 2024, the common stock subject to redemption reflected in the balance sheet are reconciled in the following table: SCHEDULE OF COMMON STOCK SUBJECT TO REDEMPTION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_4BB_zGtiNLNdPmz2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">Gross proceeds</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--GrossProceedsSubjectToRedemption_c20231001__20240930_zTZr3ODmZtki" style="width: 18%; text-align: right" title="Gross proceeds">115,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Proceeds allocated to Public Rights</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ProceedsAllocatedToPublicRights_c20231001__20240930_zwOtqg79Z5Kh" style="text-align: right" title="Proceeds allocated to Public Rights">(2,415,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common stock issuance costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--TemporaryEquityStockIssuedDuringPeriodValueNewIssues_iN_di_c20231001__20240930_zgmIPnsAYbpk" style="text-align: right" title="Common stock issuance costs">(7,571,317</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20231001__20240930_zCoUqqJ4Dn6b" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value">12,952,678</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_439_c20241001__20241231_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zTDtw5BhKbJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Common stock subject to possible redemption, September 30, 2024</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">117,966,361</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--TemporaryEquityAccretionToRedemptionValue_zy0AGgIVaap8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,083,509</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_43D_c20241001__20241231_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zGpGXS5KFXzg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Common stock subject to possible redemption, December 31, 2024</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">119,049,870</td><td style="text-align: left"> </td></tr> </table>

As of December 31, 2024, the common stock subject to redemption reflected in the balance sheet are reconciled in the following table: SCHEDULE OF COMMON STOCK SUBJECT TO REDEMPTION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_4BB_zGtiNLNdPmz2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 78%; text-align: left">Gross proceeds</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--GrossProceedsSubjectToRedemption_c20231001__20240930_zTZr3ODmZtki" style="width: 18%; text-align: right" title="Gross proceeds">115,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Proceeds allocated to Public Rights</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ProceedsAllocatedToPublicRights_c20231001__20240930_zwOtqg79Z5Kh" style="text-align: right" title="Proceeds allocated to Public Rights">(2,415,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common stock issuance costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--TemporaryEquityStockIssuedDuringPeriodValueNewIssues_iN_di_c20231001__20240930_zgmIPnsAYbpk" style="text-align: right" title="Common stock issuance costs">(7,571,317</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20231001__20240930_zCoUqqJ4Dn6b" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value">12,952,678</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_439_c20241001__20241231_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zTDtw5BhKbJc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Common stock subject to possible redemption, September 30, 2024</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">117,966,361</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Plus:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--TemporaryEquityAccretionToRedemptionValue_zy0AGgIVaap8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Remeasurement of carrying value to redemption value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,083,509</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_43D_c20241001__20241231_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zGpGXS5KFXzg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Common stock subject to possible redemption, December 31, 2024</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">119,049,870</td><td style="text-align: left"> </td></tr> </table> 115000000 -2415000

7571317

12952678

117966361

1083509

119049870

Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of December 31, 2024 and September 30, 2024, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our effective tax rate was (24.1)% for the three months ended December 31, 2024. Our effective tax rate was 0.00% for the three months ended December 31, 2023. The effective tax rate differs from the statutory tax rate of 21% for December 31, 2024 and September 30, 2024, due to the valuation allowance on the deferred tax assets. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s unaudited financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2024 and September 30, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

-0.241

0.0000

0.21

Net Income (Loss) Per Common Stock The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the period. Accretion associated with the redeemable shares of common stock is excluded from earnings (loss) per share as the redemption value approximates fair value. The calculation of diluted net income (loss) per share does not consider the effect of the rights issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the rights are contingent upon the occurrence of future events. As of December 31, 2024, the rights are exercisable to purchase 605,525 shares of common stock in the aggregate. The weighted average of these shares was excluded from the calculation of diluted net income (loss) per common stock since the inclusion of such rights would be anti-dilutive. The rights cannot be converted to shares of common stock prior to an initial Business Combination; therefore, they have been classified as anti-dilutive. IB ACQUISITION CORP. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2024 (Unaudited) The following table reflects the calculation of basic and diluted net income (loss) per common stock (in dollars, except per share amounts): SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER COMMON STOCK <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z2TfgAiCKK9b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_znB06TMnlDf3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zsrXBFQPQ6ne" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z28SzaMIFYDa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended December 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareAbstract_iB_zFSE8pbB0XO3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Basic and diluted net income (loss) per common share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 14.55pt">Allocation of net income (loss)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">662,342</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">244,726</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(87,491</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.25pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 14.55pt">Basic and diluted weighted-average shares outstanding</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zP7jN50V9Rdj" title="Basic weighted-average shares outstanding"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zLUITxbsJPz7" title="Diluted weighted average shares outstanding">11,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_ztONMZrS9VV5" title="Basic weighted-average shares outstanding"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zO8SHPJDaOFj" title="Diluted weighted average shares outstanding">4,249,090</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z4njiOjsgD1d" title="Basic weighted-average shares outstanding"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zfqEEpOsHaW2" title="Diluted weighted average shares outstanding">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z1GQJoJAUam6" title="Basic weighted-average shares outstanding"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zpefVad2y405" title="Diluted weighted average shares outstanding">2,820,513</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic and diluted net income (loss) per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3LRVxL89Ue" title="Diluted net income (loss) per common share">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z7CNrK4yzVtf" title="Basic net income (loss) per common share"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zc0uNtp09VIe" title="Diluted net income (loss) per common share">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EarningsPerShareDiluted_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zDtCzNDxsHw9" title="Diluted net income (loss) per common share">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EarningsPerShareBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyeBAgmPnbG6" title="Basic net income (loss) per common share"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zNrCK9mYN9Sa" title="Diluted net income (loss) per common share">(0.03</td><td style="text-align: left">)</td></tr> </table>

605525

The following table reflects the calculation of basic and diluted net income (loss) per common stock (in dollars, except per share amounts): SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER COMMON STOCK <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z2TfgAiCKK9b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_znB06TMnlDf3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zsrXBFQPQ6ne" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z28SzaMIFYDa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended December 31,</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the Three Months Ended December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-redeemable</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--EarningsPerShareAbstract_iB_zFSE8pbB0XO3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Basic and diluted net income (loss) per common share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left; padding-left: 14.55pt">Allocation of net income (loss)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">662,342</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">244,726</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">—</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(87,491</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 7.25pt">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 14.55pt">Basic and diluted weighted-average shares outstanding</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zP7jN50V9Rdj" title="Basic weighted-average shares outstanding"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zLUITxbsJPz7" title="Diluted weighted average shares outstanding">11,500,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_ztONMZrS9VV5" title="Basic weighted-average shares outstanding"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zO8SHPJDaOFj" title="Diluted weighted average shares outstanding">4,249,090</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z4njiOjsgD1d" title="Basic weighted-average shares outstanding"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zfqEEpOsHaW2" title="Diluted weighted average shares outstanding">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z1GQJoJAUam6" title="Basic weighted-average shares outstanding"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zpefVad2y405" title="Diluted weighted average shares outstanding">2,820,513</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic and diluted net income (loss) per common share</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_z3LRVxL89Ue" title="Diluted net income (loss) per common share">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_z7CNrK4yzVtf" title="Basic net income (loss) per common share"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20241001__20241231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zc0uNtp09VIe" title="Diluted net income (loss) per common share">0.06</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EarningsPerShareDiluted_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--RedeemableCommonStockMember_zDtCzNDxsHw9" title="Diluted net income (loss) per common share">—</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_901_eus-gaap--EarningsPerShareBasic_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zyeBAgmPnbG6" title="Basic net income (loss) per common share"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20231001__20231231__us-gaap--StatementClassOfStockAxis__custom--NonredeemableCommonStockMember_zNrCK9mYN9Sa" title="Diluted net income (loss) per common share">(0.03</td><td style="text-align: left">)</td></tr> </table>

662342

244726

-87491

11500000

4249090

2820513

0.06

-0.03

Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on the cash account and management believes that the Company is not exposed to significant risks on such account. Uninsured cash amount as of December 31, 2024, is $660,193.

250000

660193

Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Recent Accounting Standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited financial statements.

NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 11,500,000 Units, which includes a full exercise by the underwriter of their over-allotment option in the amount of <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240328__20240328__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6A8ayeEudpe" title="Number of units sold">1,500,000 Units, at a purchase price of $10.00 per Unit. <span id="xdx_901_eus-gaap--SaleOfStockDescriptionOfTransaction_pid_c20240328__20240328__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVRWqMz7rxa5" title="Sale of units, description">Each Unit consists of one share of the Company’s common stock, and one right. Each right entitles the holder thereof to receive one-twentieth (1/20) of one share of common stock upon the consummation of the Business Combination.

11500000

1500000

10.00

Each Unit consists of one share of the Company’s common stock, and one right. Each right entitles the holder thereof to receive one-twentieth (1/20) of one share of common stock upon the consummation of the Business Combination

NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor has purchased an aggregate of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240328__20240328__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zUzGYILfzLkj" title="Number of units sold">610,500 Private Placement Units at a price of $10.00 per Private Placement Unit from the Company in a private placement. Each Private Unit will consist of one share of common stock (“Private Placement Share”) and one right (“Private Placement Right”). Each Private Placement Right will entitle the holder to receive one-twentieth of one share of common stock at the closing of a Business Combination. Certain proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placements Units and all underlying securities will expire worthless.

610500

10.00

Each Private Unit will consist of one share of common stock (“Private Placement Share”) and one right (“Private Placement Right”). Each Private Placement Right will entitle the holder to receive one-twentieth of one share of common stock at the closing of a Business Combination

NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On September 2, 2020, the Sponsor subscribed to purchase an aggregate of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20200902__20200902__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zRXO94VqyXYk" title="Issuance of shares">4,312,500 shares (the “Founder Shares”) for a subscription price of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20200902__20200902__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zbB7sxi0147b" title="Subscription price">3,000. On October 26, 2023, the Sponsor agreed to surrender an aggregate of <span id="xdx_905_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pid_c20231026__20231026__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zgoH31V9qA9d" title="Number of shares surrender">1,068,910 shares of the Company’s common stock for no consideration, which were cancelled, resulting in the Sponsor holding an aggregate of 3,243,590 Founder Shares. The subsequent cancellation is retrospectively reflected in the financial statements from day one. The Company maintains the ownership of Founder Shares by the initial stockholders at <span id="xdx_901_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20240328__20240328__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_z8Uqqa8xewia" title="Ownership percentage">22.0% of the Company’s issued and outstanding shares of common stock upon the consummation of the Initial Public Offering, not including the Private Placement Shares or the Representative Shares. Up to <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240328__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zS8g9ebHsZG4" title="Common stock shares outstanding">423,077 Founder Shares held by the initial stockholders are no longer subject to forfeiture due to the underwriters’ over-allotment option exercised in full at the Initial Public Offering. The initial stockholders and the officers and directors have agreed not to transfer, assign or sell any of the Founder Shares until the earlier of (i) six months after the date of the consummation of the Business Combination or (ii) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after its initial business combination that results in all of its public stockholders having the right to exchange their shares of common stock for cash, securities or other property. <span id="xdx_901_eus-gaap--SaleOfStockDescriptionOfTransaction_pid_c20240328__20240328__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_z34xZpqaRB94" title="Sale of stock description">Notwithstanding the foregoing, if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after its initial business combination, the Founder Shares will be released from the lock-up. Due to Sponsor As of December 31, 2024 and September 30, 2024, the Company had due to Sponsor in amount of $0 and $0, respectively. The Sponsor has purchased an aggregate of <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20221001__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zGa89vS7oTNc" title="Sale of IPO shares">610,500 Private Placement Units at a price of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zeQEhhp7Wapi" title="Sale of stock price per share">10.00 per Private Placement Unit from the Company in a private placement, of which $<span id="xdx_902_eus-gaap--DepositAssets_iI_c20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z7gLxRN2jxlh" title="Shares deposited">50,000 was deposited to the Company as of September 30, 2023 to cover the Company’s operating cost and deferred offering cost and the balance was deposited with the closing of the Proposed Public Offering. Subscription Agreements From October 2023 through January 2024, the Company’s Sponsor entered into six subscription agreements to sell membership interests in the Sponsor to members of management, directors and director nominees. The membership interests represent the indirect equivalent of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20231001__20240131__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zeZpb1ZackQa" title="Number of shares issued">525,000 Founders Shares which equates to <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240131__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zOeb04uyArX7" title="Ownership percentage">16.19% of the 3,243,590 Founders Shares issued and outstanding. The total purchase price paid for the membership interests was $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20231001__20240131__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zMGjXGL12Cwe" title="Value of shares issued">2,500. The Company modified the agreements in February 2024, with the intent to clarify that the Founder Shares are “earned upon the completion of a successful Business Combination” and the modified agreement is to be effective contemporaneously with the date and time of the initial subscription agreements. The sale of the membership interests to the Company’s management, directors and director’s nominees is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. On January 22, 2024, one of the subscription agreements representing an indirect equivalent of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240122__20240122__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zqzQ3A6EPmsg" title="Number of shares terminted">100,000 Founders Shares or <span id="xdx_907_ecustom--PercentageOfSharesTerminated_pid_dp_uPure_c20240122__20240122__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zIWGdPhIua4e" title="Percentage of shares terminated">3.08% of the <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_c20240122__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zV1Su09vDgSa" title="Common stock shares issued"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240122__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zJE0oVv8MUQ4" title="Common stock shares outstanding">3,243,590 Founders Shares (with over-allotment) issued and outstanding was terminated and $<span id="xdx_90C_eus-gaap--PaymentsOfStockIssuanceCosts_c20240122__20240122__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember_zcvFmopZuAp1" title="Paid to subscriber">500 was paid to the subscriber as a result of the termination of the agreement. On September 11, 2024, one of the subscription agreements representing an indirect equivalent of <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240911__20240911__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zPcahdZnWzR2" title="Number of shares issued">100,000 Founders Shares or <span id="xdx_90C_ecustom--PercentageOfSharesTerminated_pid_dp_uPure_c20240911__20240911__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6P5PLi3hkg" title="Percentage of shares terminated">3.08% of the <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_pid_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zPNxVvoKJf5g" title="Number of shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_ztvrafLwYMqj" title="Common stock shares outstanding">3,243,590 Founders Shares (with over-allotment) issued and outstanding was amended in which the Sponsor granted an additional <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240911__20240911__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zudtz1L0uxQc" title="Number of shares issued">50,000 Founder Shares bringing the total to <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240911__20240911__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zKHqcsEAhW02" title="Number of shares terminted">150,000 Founder Shares or <span id="xdx_900_ecustom--PercentageOfSharesTerminated_pid_dp_uPure_c20240911__20240911__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z8vXi879jR8i" title="Percentage of shares terminated">4.06% of the <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zGUpAZ8esNhi" title="Number of shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240911__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zbMSdQp7B1M6" title="Number of shares held">3,243,590 Founders Shares (with over-allotment) issued and outstanding. The total purchase price paid for the membership interest was $<span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20240911__20240911__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FounderSharesMember_zNObMoIGvnSl" title="Paid to subscriber">750. The fair value of the <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240328__20240328__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectorsAndDirectorNomineesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zDZ0EiYFQqW3" title="Number of shares issued">425,000 shares granted through March 28, 2024, to the Company’s directors and director nominees was approximately $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240328__20240328__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectorsAndDirectorNomineesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_z1cEI7JqAON7" title="Number of shares issued, value">1,734,000 or approximately $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20240328__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectorsAndDirectorNomineesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zffAmDInW9Zf" title="Share price">4.08 per share. The fair value of the additional <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240912__20240912__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectorsAndDirectorNomineesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_z0q5omcGt47i" title="Number of shares issued">50,000 shares granted on September 11, 2024, to the Company’s directors and director nominees was approximately $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240912__20240912__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectorsAndDirectorNomineesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zSqN1iKw0C1" title="Number of shares issued, value">499,000 or approximately $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20240912__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectorsAndDirectorNomineesMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zETEyQOUFma" title="Share price">9.98 per share. The Founders Shares were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founders Shares is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. As of December 31, 2024, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founders Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founders Shares. <p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z2vsCj3zWkW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The Founder Shares issued to the directors and director nominees were valued using a Black-Scholes model. The following criteria presents the quantitative information regarding market assumptions used in the Founder Share valuations: SCHEDULE OF FAIR VALUE OF MARKET ASSUMPTIONS USED IN THE FOUNDER SHARE VALUATIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20231115__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zdYIp6BAfsIj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">November 15, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20240115__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zH8CuMaxSsWj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">January 15, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z4dhe5qs16m6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">5.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">5.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_40B_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zy339FKHhlY7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.1</td><td style="text-align: left">%</td></tr> <tr id="xdx_407_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zcWXdKXJl76e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Spot price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8.95</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9.46</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zA9KvaRq9sg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Discount of lack of marketability (DLOM)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zO1Z4Rh4M9dg" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify">Equity measurement input</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left">%</td></tr> </table> Administrative Services Agreement The Company entered into an Administrative Services Agreement pursuant to which the Company agreed to pay the Chief Financial Officer a sum of $5,000 per month commencing on October 1, 2023. Upon completion of the initial business combination or the liquidation, the Company will cease paying these monthly fees. On January 22, 2024, the Company’s Chief Financial Officer resigned and the Administrative Services Agreement was terminated. On January 22, 2024, the Company appointed a new Chief Financial Officer and entered into an Administrative Services Agreement dated January 24, 2024, pursuant to which the Company agreed to pay the Chief Financial Officer a sum of $5,000 per month commencing at the time of the Initial Public Offering closing. The agreement further specified that upon completion of the initial business combination or the liquidation, the Company will cease paying these monthly fees. For the three months ended December 31, 2024, the Company incurred $15,000 in fees for these services, of which $15,000 is recorded as accounts payable and accrued expenses in the balance sheets as of December 31, 2024. For the three months ended December 31, 2023, the Company incurred $15,000 in fees for these services, of which $5,000 is recorded as accounts payable and accrued expenses in the balance sheets as of December 31, 2023.

4312500

3000

1068910

3243590

0.220

423077

Notwithstanding the foregoing, if the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after its initial business combination, the Founder Shares will be released from the lock-up

610500

10.00

50000

525000

0.1619

3243590

2500

100000

0.0308

3243590

500

100000

0.0308

3243590

50000

150000

0.0406

3243590

750

425000

1734000

4.08

50000

499000

9.98

<p id="xdx_89C_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z2vsCj3zWkW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The Founder Shares issued to the directors and director nominees were valued using a Black-Scholes model. The following criteria presents the quantitative information regarding market assumptions used in the Founder Share valuations: SCHEDULE OF FAIR VALUE OF MARKET ASSUMPTIONS USED IN THE FOUNDER SHARE VALUATIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20231115__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zdYIp6BAfsIj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">November 15, 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20240115__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zH8CuMaxSsWj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">January 15, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z4dhe5qs16m6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Volatility</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">5.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">5.0</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_40B_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zy339FKHhlY7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.1</td><td style="text-align: left">%</td></tr> <tr id="xdx_407_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zcWXdKXJl76e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Spot price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8.95</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9.46</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zA9KvaRq9sg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Discount of lack of marketability (DLOM)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left">%</td></tr> <tr id="xdx_40D_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zO1Z4Rh4M9dg" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify">Equity measurement input</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.4</td><td style="text-align: left">%</td></tr> </table>

5.0

4.8

4.1

8.95

9.46

0.2

0.4

0.2

0.4

5000

15000

5000

NOTE 6. COMMITMENTS AND CONTINGENCY Registration Rights The holders of the Founder Shares, Private Placement Units (and their underlying securities) any Units that may be issued upon conversion of the Working Capital Loans (and underlying securities), and Representative Shares are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement and Business Combination Marketing Agreement The Company engaged I-Bankers to act as Underwriters on the Initial Public Offering of the Company’s Units, for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240328__20240328__us-gaap--TypeOfArrangementAxis__custom--UnderwritersAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDKLgDCAooG6" title="Stock issued during period value">115,000,000 and the simultaneous listing on the Nasdaq Global Market. The Underwriters had a 30-day option to purchase up to an additional <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240328__20240328__us-gaap--TypeOfArrangementAxis__custom--UnderwritersAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zMH1d0Wu78Y" title="Stock issued during period shares">1,500,000 Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On March 28, 2024, simultaneously with the closing of the Initial Public Offering, the Underwriters elected to fully exercise the over-allotment option to purchase an additional <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240328__20240328__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zIfxaGvDJ5S2" title="Number of units sold">1,500,000 Units at a price of $10.00 per Unit. The Underwriters were entitled to a cash underwriting discount of $<span id="xdx_90D_ecustom--CashUnderwritingDiscountPerUnit_iI_pid_c20240328__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritersAgreementMember_zBvHFmZGrro9" title="Cash underwriting discount per unit">0.30 per Unit, or $<span id="xdx_900_eus-gaap--PaymentsForUnderwritingExpense_c20240328__20240328__us-gaap--TypeOfArrangementAxis__custom--UnderwritersAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z1xBwOWBT0Gf" title="Cash underwriting fees">3,450,000 in the aggregate, paid upon the closing of the Initial Public Offering. In addition, under a business combination marketing agreement, the Company engaged I-Bankers to provide marketing services in connection with the Business Combination and will pay I-Bankers a cash fee for such marketing services upon the consummation of the Business Combination in an amount equal to, in the aggregate, <span id="xdx_909_eus-gaap--ManagementAndServiceFeesRate_pid_dp_uPure_c20240328__20240328__us-gaap--TypeOfArrangementAxis__custom--UnderwritersAgreementMember_zXfBbzeopEEf" title="Percentage of cash fee for service">3.5% of the gross proceeds of the Initial Public Offering (the “M&A fee”) or $4,025,000 in the aggregate. If the Company doesn’t complete a business combination, no fee will be due. In addition, the Company will pay the I-Bankers a finder fee equal to 1.0% of the consideration issued to a target if the business combination is consummated with a target introduced by the I-Bankers. On the closing of the Initial Public Offering, pursuant to the underwriting agreement, the Company issued as compensation <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationGross_c20240328__20240328__us-gaap--TypeOfArrangementAxis__custom--UnderwritersAgreementMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znod6VNXCj5c" title="Shares issued for compensation">395,000 shares of common stock for no cash consideration (the “Representative Shares”). Working Capital Loan On September 16, 2024, the Company issued an unsecured promissory note in the principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20240916__us-gaap--LongtermDebtTypeAxis__custom--UnsecuredPromissoryNoteMember__dei--LegalEntityAxis__custom--SuDeTangGlobalCorporationMember_zgvKGedWlNc1" title="Note principal amount">150,000 to Su De Tang Global Corporation (the “Working Capital Loan”). The principal balance of this Promissory Note represents the first of potentially three instalments of the Working Capital Loan. The Working Capital Loan bears no interest and will be extinguished without any payment required at the consummation of a Business Combination with Su De Tang Global Corporation. The Company has borrowed a total of $<span id="xdx_906_eus-gaap--OtherBorrowings_iI_c20241231__us-gaap--LongtermDebtTypeAxis__custom--UnsecuredPromissoryNoteMember__dei--LegalEntityAxis__custom--SuDeTangGlobalCorporationMember_znkj5ykhXFgh" title="Borrowings">147,629 under the Working Capital Loan and an aggregate of $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityRemainingBorrowingCapacity_iI_c20241231__us-gaap--LongtermDebtTypeAxis__custom--UnsecuredPromissoryNoteMember__dei--LegalEntityAxis__custom--SuDeTangGlobalCorporationMember_zl5ltlSHFtr3" title="Loan remaining borrowing available amount">2,371 remains available to borrow under the Working Capital Loan as of December 31, 2024.

115000000

1500000

10.00

0.30

3450000

0.035

4025000 0.010

395000

150000

147629

2371

NOTE 7. STOCKHOLDERS’ EQUITY Preferred Stock — The Company is authorized to issue 10,000,000 shares of preferred stock with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2024 and September 30, 2024, there were no shares of preferred stock issued or outstanding. Common Stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of common stock are entitled to one vote for each share. As of December 31, 2024 and September 30, 2024, there were 4,249,090 shares of common stock issued and outstanding, excluding 11,500,000 shares of common stock subject to possible redemption.

10000000

0.0001

100000000

0.0001

Holders of common stock are entitled to one vote for each share

4249090

11500000

NOTE 8. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in; padding-right: 0.8pt; text-align: justify">Level 1:</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.8pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.8pt; text-align: justify">Level 2:</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.8pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.8pt; text-align: justify">Level 3:</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.8pt; text-align: justify">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</td></tr> </table> As of December 31, 2024, assets held in the Trust Account were comprised of $119,658,403 in a mutual fund that is invested primarily in U.S. Treasury Securities. For the three months ended December 31, 2024, the Company did not withdraw any interest earned on the Trust Account. As of September 30, 2024, assets held in the Trust Account were comprised of $118,601,873 in a mutual fund that is invested primarily in U.S. Treasury Securities. Through September 30, 2024, the Company has not withdrawn any of the interest earned on the Trust Account. IB ACQUISITION CORP. NOTES TO FINANCIAL STATEMENTS DECEMBER 31, 2024 (Unaudited) The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.: SCHEDULE OF ASSETS AND LIABILITIES MEASURED FAIR VALUE ON RECURRING BASIS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Description</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 43%; text-align: justify">Marketable securities held in trust account</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">1</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsHeldInTrust_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpNgaBXRnyn2" style="width: 16%; text-align: right" title="Marketable securities held in trust account">119,658,403</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsHeldInTrust_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zji1qPgbKp7g" style="width: 16%; text-align: right" title="Marketable securities held in trust account">118,601,873</td><td style="width: 1%; text-align: left"> </td></tr> </table>

119658403

118601873

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.: SCHEDULE OF ASSETS AND LIABILITIES MEASURED FAIR VALUE ON RECURRING BASIS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Description</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 43%; text-align: justify">Marketable securities held in trust account</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">1</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsHeldInTrust_iI_c20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpNgaBXRnyn2" style="width: 16%; text-align: right" title="Marketable securities held in trust account">119,658,403</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsHeldInTrust_iI_c20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zji1qPgbKp7g" style="width: 16%; text-align: right" title="Marketable securities held in trust account">118,601,873</td><td style="width: 1%; text-align: left"> </td></tr> </table>

119658403

118601873

NOTE 9. SEGMENT INFORMATION ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance. The Company’s chief operating decision maker has been identified as the Chief Financial Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics, which includes general and administrative expenses and interest earned on marketable securities held in Trust Account which are included in the accompanying unaudited statements of operations. The key measures of segment profit or loss reviewed by our CODM are earned on marketable securities held in Trust Account and general and administrative expenses. The CODM reviews earned on marketable securities held in Trust Account to measure and monitor stockholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.

NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited financial statements.

Excluded an aggregate of 423,077 shares subject to possible forfeiture at December 31, 2023. An aggregate of up to 423,077 shares subject to possible forfeiture at the closing of proposed public offering